Cargando…

Secondary penicillin prophylaxis for latent rheumatic heart disease: A naïve realism?

Detalles Bibliográficos
Autor principal:	Kothari, Shyam S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Personal View Point
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593280/ https://www.ncbi.nlm.nih.gov/pubmed/37876959 http://dx.doi.org/10.4103/apc.apc_61_23

Ejemplares similares

Secondary Prevention of Rheumatic Heart Disease in Nepal: Are We Going Backward?
por: Regmi, Prakash Raj, et al.
Publicado: (2022)

Rheumatic fever pathogenesis: Approach in research needs change
por: Tandon, Rajendra
Publicado: (2012)

Making of a pediatric cardiac surgeon, in India
por: Sharma, Rajesh
Publicado: (2008)

The Burden of Congenital Heart Disease in Libya
por: Aburawi, Elhadi H
Publicado: (2006)

Can We Treat Secondary Progressive Multiple Sclerosis Now?
por: Bhatia, Rohit, et al.
Publicado: (2019)

New Threat at Doorstep: What an Intensivist should Know
por: Das, Akshaya Kumar, et al.
Publicado: (2022)

Building effective multilevel HIV prevention partnerships with Black men who have sex with men: experience from HPTN 073, a pre‐exposure prophylaxis study in three US cities
por: Wheeler, Darrell P, et al.
Publicado: (2018)

Classification of heart failure: A farewell to ejection fraction?
por: Lüscher, Thomas F.
Publicado: (2020)

Young@Heart: empowering the next generation of cardiovascular researchers
por: Hoes, M. F., et al.
Publicado: (2020)

The digital heart–lung unit: applications of exponential technology
por: Sadeghi, Amir H, et al.
Publicado: (2021)

Treatment decision for transcatheter aortic valve implantation: the role of the heart team: Position statement paper of the Dutch Working Group of Transcatheter Heart Interventions
por: de Jaegere, P. P. T., et al.
Publicado: (2020)

Diverse stakeholder engagement at the heart of co-designing cardiac arrest care
por: Paratz, Elizabeth D., et al.
Publicado: (2022)

Need to Bring Family to the Heart of Healthcare as it is Home, not a Hospital, Where Healthcare Begins and Ends
por: Kumar, Sanjiv, et al.
Publicado: (2023)

QRS Voltage Changes in Heart Failure: A 3-Compartment Mechanistic Model and its Implications
por: Madias, John E
Publicado: (2010)

Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital
por: Musoke, Charles, et al.
Publicado: (2013)

Remote monitoring of pulmonary artery pressures with CardioMEMS in patients with chronic heart failure and NYHA class III: first experiences in the Netherlands
por: Brugts, J. J., et al.
Publicado: (2017)

Neurosarcoidosis: The Pan-Neurology Disease
por: Agarwal, Ayush, et al.
Publicado: (2023)

Digital Therapeutics for MCI and Alzheimer’s disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer’s Disease conference (CTAD)
por: Shuren, J., et al.
Publicado: (2022)

Is PIGD a legitimate motor subtype in Parkinson disease?
por: Kotagal, Vikas
Publicado: (2016)

Teleneurorehabilitation for Parkinson’s Disease: A Panacea for the Times to Come?
por: Garg, Divyani, et al.
Publicado: (2020)

Overcoming obstacles to repurposing for neurodegenerative disease
por: Shineman, Diana W, et al.
Publicado: (2014)

Role of Vitamin D in Cerebrovascular Disease
por: Kaul, Subhash, et al.
Publicado: (2021)

Parkinson's Disease and Wearable Technology: An Indian Perspective
por: Bagrodia, Vaishali, et al.
Publicado: (2022)

Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?
por: deSouza, Ruth-Mary, et al.
Publicado: (2013)

Anticancer Drugs for Parkinson's Disease: Is It a Ray of Hope or Only Hype?
por: Dash, Deepa, et al.
Publicado: (2019)

Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective
por: Rostoker, Guy, et al.
Publicado: (2021)

Novel Coronavirus Disease: A delicate balancing act between health and the economy
por: Moti, Ukertor Gabriel, et al.
Publicado: (2020)

COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology
por: Puig-Domingo, M., et al.
Publicado: (2020)

Disease-Modifying Therapy in Subacute Sclerosing Panencephalitis: An Area of Darkness
por: Garg, Divyani, et al.
Publicado: (2023)

Disability Certification for Parkinson’s Disease in India: Challenges and the Way Forward
por: Arun, M, et al.
Publicado: (2023)

Relevance of Primary Health Care in Controlling Noncommunicable Diseases in India
por: Nandan, Deoki, et al.
Publicado: (2011)

Synaptic dysfunction and oxidative stress in Alzheimer’s disease: Emerging mechanisms
por: Forero, D A, et al.
Publicado: (2006)

An appeal to our government for nationwide policies in the prevention of cardiovascular disease
por: van Trier, T. J., et al.
Publicado: (2021)

Need for integrative thinking to fight against emerging infectious diseases. Proceedings of the 5th seminar on emerging infectious diseases, March 22, 2016 – current trends and proposals
por: Burdet, C., et al.
Publicado: (2018)

Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience
por: Tan, Eng-King, et al.
Publicado: (2021)

Newer insights to the neurological diseases among biblical characters of old testament
por: Mathew, Stephen K., et al.
Publicado: (2010)

Alzheimer disease in post-menopausal women: Intervene in the critical window period
por: Jamshed, Nayer, et al.
Publicado: (2014)

No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts
por: Pandit, Lekha
Publicado: (2019)

The Challenge of Managing Parkinson’s Disease Patients during the COVID-19 Pandemic
por: Garg, Divyani, et al.
Publicado: (2020)

Multi-sectorial research is paramount for preventing and controlling emerging infectious diseases
por: Le Turnier, P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1sl5thbqb44l4lkgsmv7o2qt9u